BDBM474224 5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] methyl]-7-(4-fluorophenyl)-[l, 2,4]Jtriazolo[l,5-c] pyrimidin-8-yl)-1-methyl-1,2-dihydropyridin-2-one::US10858365, Compound 20::US11629147, Cmpd. 20

SMILES Cn1cc(ccc1=O)-c1c(nc(N)n2nc(Cc3ncccc3OC(F)F)nc12)-c1ccc(F)cc1

InChI Key InChIKey=IVLZUGWDYRIRPP-UHFFFAOYSA-N

Data  13 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 13 hits for monomerid = 474224   

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 2.80nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 4nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 8.70nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 1.07E+3nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 3.5nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 84nMAssay Description:hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Mouse)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 4.90nMAssay Description:hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 34nMAssay Description:hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 1.00E+4nMAssay Description:hADORA1/CHO (hA1 expressing) cells (Genscript) were plated at 1×104 cells/well into 384-well polystyrene plates one day before starting the experimen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/11/2021
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 2.80nMAssay Description:Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characteriz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 4nMAssay Description:Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characteriz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A2b(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 8.70nMAssay Description:Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characteriz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
TBA

US Patent
LigandPNGBDBM474224(5-(5-amino-2-[[3-(difluoromethoxy)pyridin-2-yl] me...)
Affinity DataIC50: 1.07E+3nMAssay Description:Binding affinity and specificities of the compounds against different subtype of human adenosine receptors (hA1, hA2A, hA2B and hA3) were characteriz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
Go to US Patent